Eric Winquist

Eric Winquist

UNVERIFIED PROFILE

Are you Eric Winquist?   Register this Author

Register author
Eric Winquist

Eric Winquist

Publications by authors named "Eric Winquist"

Are you Eric Winquist?   Register this Author

100Publications

2815Reads

45Profile Views

Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancer.

Oral Oncol 2019 Dec 19;101:104529. Epub 2019 Dec 19.

Department of Otolaryngology, London Health Sciences Centre, London, Ontario, Canada; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2019.104529DOI Listing
December 2019

Early experience with chemotherapy intensification for poor prognosis metastatic germ cell cancer and unfavorable tumor marker decline.

Can Urol Assoc J 2019 Jul 23. Epub 2019 Jul 23.

Division of Medical Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5489/cuaj.5802DOI Listing
July 2019

Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients.

Oral Oncol 2019 02 21;89:72-78. Epub 2018 Dec 21.

Department of Medicine, Western University, 1151 Richmond St., London, ON N6A3K7, Canada; Department of Physiology and Pharmacology, Medical Sciences Building, UWO, London, ON N6A 5C1, Canada; Department of Oncology, Division of Experimental Oncology, London Health Sciences Centre, Western University, 800 Commissioners Rd. E., London, ON N6A5W9, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S13688375183046
Publisher Site
http://dx.doi.org/10.1016/j.oraloncology.2018.12.010DOI Listing
February 2019

Emerging cell cycle inhibitors for treating metastatic castration-resistant prostate cancer.

Expert Opin Emerg Drugs 2018 12 28;23(4):271-282. Epub 2018 Nov 28.

a Division of Medical Oncology, Department of Oncology, Schulich School of Medicine & Dentistry , Western University and London Health Sciences Centre , London , ON , Canada.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14728214.2018.1
Publisher Site
http://dx.doi.org/10.1080/14728214.2018.1547707DOI Listing
December 2018

Late Relapse of Ovarian Germ Cell Tumour.

J Obstet Gynaecol Can 2018 10;40(10):1329-1332

Schulich School of Medicine & Dentistry, Western University and London Health Sciences Centre, London, ON; Division of Urology, Department of Surgery, London Health Sciences Centre, London, ON. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jogc.2018.02.021DOI Listing
October 2018

Editorial Comment.

Authors:
Eric Winquist

J Urol 2018 08 8;200(2):351-352. Epub 2018 May 8.

Department of Oncology, Western University, London Health Sciences Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2018.03.142DOI Listing
August 2018

The Clinical Significance of Occult Gastrointestinal Primary Tumours in Metastatic Cancer: A Population Retrospective Cohort Study.

Cancer Res Treat 2018 Jan 21;50(1):183-194. Epub 2017 Mar 21.

Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2016.532DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784645PMC
January 2018

Dose dense MVAC prior to radical cystectomy: a real-world experience.

World J Urol 2017 Nov 17;35(11):1729-1736. Epub 2017 Jun 17.

Department of Surgery (Division of Urology), McGill University Health Center, Montreal, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-017-2065-xDOI Listing
November 2017

Case: Secondary polycythemia due to pazopanib in patients with metastatic renal cell carcinoma.

Can Urol Assoc J 2017 Nov;11(11):E449-E450

Division of Medical Oncology, Department of Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5489/cuaj.4519DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698026PMC
November 2017

Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis.

Ann Intern Med 2017 Sep 8;167(5):341-350. Epub 2017 Aug 8.

From University of Toronto, University Health Network, Odette Cancer Centre, and Princess Margaret Hospital, Toronto; McMaster University and Juravinski Cancer Centre, Hamilton; University of Ottawa and The Ottawa Hospital Cancer Centre, Ottawa; and Western University and London Health Sciences Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M16-2577DOI Listing
September 2017

The "Dirty Harry" Approach.

Int J Radiat Oncol Biol Phys 2017 09 7;99(1). Epub 2017 Aug 7.

Division of Medical Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.05.036DOI Listing
September 2017

Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion.

J Clin Oncol 2017 Jun 25;35(17):1952-1964. Epub 2017 Apr 25.

Katherine S. Virgo, Emory University, Atlanta, GA; Ethan Basch, University of North Carolina, Chapel Hill, NC; D. Andrew Loblaw, Sunnybrook Health Sciences Centre, Toronto; Eric Winquist, London Health Sciences Centre, London, Ontario, Canada; Thomas K. Oliver and R. Bryan Rumble, American Society of Clinical Oncology, Alexandria, VA; Michael A. Carducci, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Luke Nordquist, Urology Cancer Center and GU Research Network, Omaha, NE; Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston, MA; and Eric A. Singer, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.8030DOI Listing
June 2017

Chronic Oxaliplatin-Based Chemotherapy in a Primary Ampullary Adenocarcinoma Patient without Significant Peripheral Neuropathy: Case Report and Literature Review.

Case Rep Oncol 2017 May-Aug;10(2):577-581. Epub 2017 Jun 29.

Division of Medical Oncology, Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000477841DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567005PMC
June 2017

Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic review.

J Otolaryngol Head Neck Surg 2017 Apr 4;46(1):29. Epub 2017 Apr 4.

Sunnybrook Odette Cancer Centre, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40463-017-0199-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381126PMC
April 2017

Pretreatment Serum Folate Levels and Toxicity/Efficacy in Colorectal Cancer Patients Treated With 5-Fluorouracil and Folinic Acid.

Clin Colorectal Cancer 2016 12 23;15(4):369-376.e3. Epub 2016 Jun 23.

Division of Medical Oncology, Department of Oncology, London Health Sciences Centre and University of Western Ontario, London, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2016.06.001DOI Listing
December 2016

Sunitinib maintenance therapy after response to docetaxel in metastatic castration resistant prostate cancer (mCRPC).

Invest New Drugs 2016 12 26;34(6):771-776. Epub 2016 Aug 26.

Department of Medical Oncology, BC Cancer Agency, Vancouver Cancer Centre, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-016-0386-zDOI Listing
December 2016

Validation of a prediction model for avoiding post-chemotherapy retroperitoneal lymphadenectomy in patients with metastatic nonseminomatous germ cell cancer.

Can Urol Assoc J 2016 Aug;10(7-8):260-263

Division of Medical Oncology, Western University and London Health Sciences Centre, London, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5489/cuaj.3558DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110407PMC
August 2016

Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options--An Analysis From the Global Germ Cell Cancer Group.

J Clin Oncol 2016 Feb 12;34(4):345-51. Epub 2015 Oct 12.

Darren R. Feldman, Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, New York, NY; Anja Lorch, University Hospital Düsseldorf, Düsseldorf; Carsten Bokemeyer, University Hospital Eppendorf, Hamburg, Germany; Andrew Kramar, Centre Oscar Lambret, Lille; Aude Flechon and Helen Boyle, Centre Léon Bérard, Lyon, France; Costantine Albany and Lawrence H. Einhorn, Indiana University, Bloomington, IN; Patrizia Giannatempo and Andrea Necchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milano; Teodoro Sava, Azienda Ospedaliera Universitaria Integrata di Verona, Verona; Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Istituto di Ricovero e Cura a Carattere Scientifico, Meldola, Italy; Peter Chung, Princess Margaret Cancer Centre, University of Toronto, Toronto; Eric William Winquist, London Health Sciences Center, London, Ontario, Canada; Robert A. Huddart, Royal Marsden Hospital; Thomas Powles, St Bartholomew's Hospital, London, United Kingdom; Alexey Tryakin, Blokhin's Russian Cancer Research Center, Moscow, Russia; Jorge Aparicio, University Hospital Le Fe, Valencia, Spain; Christopher J. Sweeney, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Gabriella Cohn Cedermark, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden; and Jörg Beyer, UniversitätsSpital Zürich, Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.62.7000
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.62.7000DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070579PMC
February 2016

Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma.

Pathol Oncol Res 2016 Jan 14;22(1):35-40. Epub 2015 Aug 14.

Department of Otolaryngology - Head and Neck Surgery, Schulich School of Medicine & Dentistry, Western University, 800 Commissioners Rd. E., London, ON, N6A 5W9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12253-015-9970-3DOI Listing
January 2016

Do retroperitoneal extragonadal germ cell tumours exist?

Can Urol Assoc J 2015 Nov-Dec;9(11-12):381-4. Epub 2015 Dec 14.

Division of Urology, London Health Sciences Centre, Western University, London, ON;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5489/cuaj.3024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707886PMC
January 2016

Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.

Acta Oncol 2015 Nov 31;54(10):1781-7. Epub 2015 Mar 31.

a Department of Epidemiology and Biostatistics , Western University , London , Ontario , Canada.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/0284186X.2015.10
Publisher Site
http://dx.doi.org/10.3109/0284186X.2015.1020965DOI Listing
November 2015

A Population-Based Study of 30-day Incidence of Ischemic Stroke Following Surgical Neck Dissection.

Medicine (Baltimore) 2015 Aug;94(33):e1106

Department of Otolaryngology-Head and Neck Surgery, Western University, London (SDM, ST, JY, AN, KF); Institute for Clinical and Evaluative Sciences (SDM, KL, AXG, AT, SH, SZS); Department of Epidemiology and Biostatistics, Western University (AXG, AT); Department of Family Medicine, Western University (AT); Department of Oncology, Western University, London (SDM, DP, EW, JY, AN, KF); Department of Otolaryngology-Head and Neck Surgery, Cancer Care and Epidemiology, Queens University, Kingston (SH); Department of Medicine, Division of Nephrology, Western University, London, Ontario, Canada (AXG).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000001106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616442PMC
August 2015

Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapy.

J Clin Oncol 2015 Feb 20;33(6):582-7. Epub 2015 Jan 20.

Amirrtha Srikanthan, Ben Tran, Michael A.S. Jewett, Robert J. Hamilton, Lynn Anson-Cartwright, Peter W.M. Chung, Padraig R. Warde, Martin O'Malley, Malcolm J. Moore, Eitan Amir, and Philippe L. Bedard, Princess Margaret Cancer Centre, University of Toronto, Toronto; Michel Beausoleil and Eric Winquist, Western University and London Health Sciences Centre, London, Ontario; Jeremy F.G. Sturgeon, McGill University, Montreal, Quebec, Canada; and Ben Tran, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/01/20/JCO.2014.58
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.58.6537
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.58.6537DOI Listing
February 2015

Toward a functional definition of a "rare disease" for regulatory authorities and funding agencies.

Value Health 2014 Dec 18;17(8):757-61. Epub 2014 Oct 18.

Schulich School of Medicine & Dentistry, Western University, London, ON, Canada; London Health Sciences Centre, London, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2014.08.2672DOI Listing
December 2014

Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline.

J Clin Oncol 2014 Oct 8;32(30):3436-48. Epub 2014 Sep 8.

Ethan Basch, Ronald C. Chen, and Stacie B. Dusetzina, University of North Carolina, Chapel Hill; Derek Raghavan, Carolinas Health Care/Levine Cancer Institute, Charlotte, NC; D. Andrew Loblaw, Odette Cancer Centre, Sunnybrook Health Sciences Centre; Ted Wootton, Patient Representatives, Toronto; Sebastian Hotte and Cindy Walker-Dilks, McMaster University; Cindy Walker-Dilks, Cancer Care Ontario, Hamilton; Eric Winquist, London Health Sciences Centre, London, Ontario; Fred Saad, University of Montreal, Montreal, Quebec, Canada; Thomas K. Oliver and R. Bryan Rumble, American Society of Clinical Oncology, Alexandria, VA; Michael Carducci, Johns Hopkins University, Baltimore, MD; James N. Frame, Charleston Area Medical Center Health Systems, Charleston, WV; Kristina Garrels, Private Practice, Fargo, ND; Michael W. Kattan, Cleveland Clinic, Cleveland, OH; Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston, MA; James Williams, Pennsylvania Prostate Cancer Coalition, Camp Hill, PA; Charles L. Bennett, South Carolina College of Pharmacy, Columbia, SC; and Katherine S. Virgo, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.8404DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876355PMC
October 2014

ECF chemotherapy for liver metastases due to castration-resistant prostate cancer.

Can Urol Assoc J 2014 Sep;8(9-10):353-7

Schulich School of Medicine & Dentistry, Western University, London, ON; ; Division of Medical Oncology, Department of Oncology, Western University, London, ON;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5489/cuaj.2029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216294PMC
September 2014

Application of a policy framework for the public funding of drugs for rare diseases.

J Gen Intern Med 2014 Aug;29 Suppl 3:S774-9

Schulich School of Medicine & Dentistry, Western University; and London Health Sciences Centre, 790 Commissioners Road East, London, ON, Canada, N6A 4L6,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11606-014-2885-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124122PMC
August 2014

Tamoxifen-associated hot flash severity is inversely correlated with endoxifen concentration and CYP3A4*22.

Breast Cancer Res Treat 2014 Jun 18;145(2):419-28. Epub 2014 Apr 18.

Division of Clinical Pharmacology, Department of Medicine, LHSC-University Hospital, Western University, Room B9-132, 339 Windermere Road, London, ON, N6A 5A5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2963-1DOI Listing
June 2014

Secondary hormonal manipulation in castration resistant prostate cancer.

Can J Urol 2014 Apr;21(2 Supp 1):37-41

London Health Sciences Centre and Western University, London, Ontario, Canada.

View Article

Download full-text PDF

Source
April 2014

Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients.

Laryngoscope 2014 Mar 1;124(3):E87-94. Epub 2013 Oct 1.

Department of Audiology, London Health Sciences Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/lary.24360DOI Listing
March 2014

Can radiological changes in lymph node volume during treatment predict success of radiation therapy in patients with locally advanced head and neck squamous cell carcinoma?

J Med Imaging Radiat Oncol 2013 Oct 8;57(5):603-9. Epub 2013 May 8.

Division of Radiation Oncology, London Health Sciences Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1754-9485.12067DOI Listing
October 2013

A case report and genetic characterization of a massive acinic cell carcinoma of the parotid with delayed distant metastases.

Case Rep Oncol Med 2013 3;2013:270362. Epub 2013 Apr 3.

Department of Otolaryngology Head and Neck Surgery, The University of Western Ontario, Victoria Hospital, London Health Science Centre, Room B3-431A, 800 Commissioners Road East, London, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/270362DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638544PMC
August 2013

High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancer.

JAMA Otolaryngol Head Neck Surg 2013 Jun;139(6):617-22

Victoria Hospital, London Health Science Centre, Department of Otolaryngology–Head and Neck Surgery, Room B3-431A, 800 Commissioners Rd E, London, ON N6A 5W9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoto.2013.3210DOI Listing
June 2013

Custirsen (OGX-011): clusterin inhibitor in metastatic prostate cancer.

Curr Oncol Rep 2013 Apr;15(2):113-8

Division of Medical Oncology, Department of Oncology, Western University, London, ON, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11912-012-0285-1
Publisher Site
http://dx.doi.org/10.1007/s11912-012-0285-1DOI Listing
April 2013

An evaluation framework for funding drugs for rare diseases.

Value Health 2012 Sep-Oct;15(6):982-6

London Health Sciences Centre and Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2012.06.009DOI Listing
December 2012

Open clinical uro-oncology trials in Canada.

Can J Urol 2012 Dec;19(6):6587-91

London Health Sciences Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
December 2012

Cost-effectiveness of adding cetuximab to platinum-based chemotherapy for first-line treatment of recurrent or metastatic head and neck cancer.

PLoS One 2012 20;7(6):e38557. Epub 2012 Jun 20.

Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0038557PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379991PMC
November 2012

Open clinical uro-oncology trials in Canada.

Can J Urol 2012 Oct;19(5):6489-93

London Health Sciences Centre, Ontario, Canada.

View Article

Download full-text PDF

Source
October 2012

Effects of funding policy changes and health warnings on the use of erythropoiesis-stimulating agents.

J Oncol Pract 2012 May 17;8(3):179-83. Epub 2012 Jan 17.

University of Western Ontario, London; University of Waterloo, Waterloo; Institute for Clinical Evaluative Sciences; University of Toronto; Sunnybrook Health Sciences Centre; and Applied Health Research Center, Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.2011.000287
Publisher Site
http://dx.doi.org/10.1200/JOP.2011.000287DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396807PMC
May 2012

A phase I study of temsirolimus and metformin in advanced solid tumours.

Invest New Drugs 2012 Apr 27;30(2):647-52. Epub 2010 Oct 27.

London Health Sciences Centre, 790 Commissioners Rd. East, London, ON, Canada N6A 4L6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-010-9570-8DOI Listing
April 2012

Open clinical uro-oncology trials in Canada.

Can J Urol 2012 Apr;19(2):6232-7

London Health Sciences Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
April 2012

Open clinical uro-oncology trials in Canada.

Can J Urol 2012 Feb;19(1):6135-41

London Health Sciences Centre, Ontario, Canada.

View Article

Download full-text PDF

Source
February 2012

Open clinical uro-oncology trials in Canada.

Can J Urol 2011 Dec;18(6):6054-9

View Article

Download full-text PDF

Source
December 2011

A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium.

Invest New Drugs 2011 Oct 27;29(5):1045-9. Epub 2010 Feb 27.

Princess Margaret Hospital, Phase II Consortium, 610 University Avenue, Suite 5-222, Toronto, Ontario M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-010-9408-4
Publisher Site
http://dx.doi.org/10.1007/s10637-010-9408-4DOI Listing
October 2011

Open clinical uro-oncology trials in Canada.

Can J Urol 2011 Oct;18(5):5928-32

London Health Sciences Centre, Ontario, Canada.

View Article

Download full-text PDF

Source
October 2011

Recent advances in second-line treatment of castration-resistant prostate cancer.

Curr Opin Support Palliat Care 2011 Sep;5(3):199-205

Division of Medical Oncology, Department of Oncology, University of Western Ontario, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SPC.0b013e32834903aaDOI Listing
September 2011

Open clinical uro-oncology trials in Canada.

Can J Urol 2011 Aug;18(4):5849-55

London Health Sciences Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
August 2011

Open clinical uro-oncology trials in Canada.

Can J Urol 2011 Jun;18(3):5751-6

London Health Sciences Centre, Ontario, Canada.

View Article

Download full-text PDF

Source
June 2011

Open clinical uro-oncology trials in Canada.

Can J Urol 2011 Apr;18(2):5650-6

London Health Sciences Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
April 2011

Open clinical uro-oncology trials in Canada.

Can J Urol 2011 Feb;18(1):5574-80

London Health Sciences Centre, Ontario, Canada.

View Article

Download full-text PDF

Source
February 2011

Open clinical uro-oncology trials in Canada.

Can J Urol 2010 Dec;17(6):5494-9

London Health Sciences Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
December 2010

Open clinical uro-oncology trials in Canada.

Can J Urol 2010 Oct;17(5):5419-23

London Health Sciences Centre, Ontario, Canada.

View Article

Download full-text PDF

Source
October 2010

Open clinical uro-oncology trials in Canada.

Can J Urol 2010 Aug;17(4):5338-42

London Health Sciences Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
August 2010

Open clinical uro-oncology trials in Canada.

Can J Urol 2010 Jun;17(3):5239-44

London Health Sciences Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
June 2010

Open clinical uro-oncology trials in Canada.

Can J Urol 2010 Apr;17(2):5141-7

London Health Sciences Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
April 2010

Open clinical uro-oncology trials in Canada.

Can J Urol 2010 Feb;17(1):5050-6

London Health Sciences Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
February 2010

Open clinical uro-oncology trials in Canada.

Can J Urol 2009 Dec;16(6):4964-70

London Health Sciences Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
December 2009